by Paul Enck
A recent randomized has found that a fermented milk containing multiple probiotic strains and a prebiotic fibre may help manage constipation in patients with PD.
by Paul Enck
A recent study, led by Dr. Paul Wilmes from the Luxembourg Centre for Systems Biomedicine at the University of Luxembourg (Luxembourg), adds new insights about the human microbiome in type 1 diabetes mellitus (T1DM) from an integrated multi-omics analysis.
by Paul Enck
A recent systematic review and meta-analysis has shown that the consumption of a probiotic fermented milk with Bifidobacterium lactis (B. lactis) CNCM I-2494 and lactic acid bacteria may improve outcomes related to mild gastrointestinal discomfort in healthy female adults.
by Paul Enck
A recent systematic review and meta-analysis, led by Dr. C-X Pei from The First Clinical Medical College and Evidence Based Medical Centre of Lanzhou University in Lanzhou (China), has shown that probiotics may have a role in prevention of chemoradiotherapy-induced diarrhoea in people with abdominal and pelvic cancer, and are rarely associated with adverse events.
by Paul Enck
A recent review, led by Dr. Vassilis Pachnis from the Francis Crick Institute in London (United Kingdom), discusses recent advances on the role of gut microbiota and the immune system on the development of the ENS.
by Paul Enck
A recent study, led by Prof. Brian K. Coombes from the Department of Biochemistry and Biomedical Sciences at the McMaster University in Hamilton, Ontario (Canada), has found that AIEC colonization along with acute infectious gastroenteritis worsened clinical outcome and increased mortality in mice, and also that the infectious diarrhoea caused by microbes promoted growth of AIEC and heightened the inflammatory state in the gut.
by Paul Enck
A recent study, led by Vanessa Stadlbauer from the Department of Gastroenterology and Hepatology, Medical University of Graz, in Graz (Austria), has found that a multispecies probiotic may have beneficial effects on immune function in patients with cirrhosis.
by Paul Enck
A recent study, led by Mr. Michael Shahani from Nebraska Cultures in Walnut Creek (California, USA), has found that a specific strain of Lactobacillus acidophilus may provide symptom benefits after 4 weeks of use, compared with a placebo, among individuals with lactose intolerance.
by Paul Enck
A recent case-control study, led by Dr. Zhenjun Wu from the Department of Blood Transfusion and Clinical Laboratory at Qingdao University School of Medicine in Qingdao (China), has found that probiotics may combat SIBO in patients with gastrointestinal cancer and may alleviate some gastrointestinal symptoms.
Inflammatory bowel disease (IBD) is a family of intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) that are characterized by chronic and recurring periods of severe colonic (UC) or intestinal (CD) inflammation and extraintestinal symptoms.
